Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.10
+0.29 (4.99%)
Jul 27, 2026, 9:41 AM EDT - Market open

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-44.47-38.58-25.5-28.22-18.49-18.93
Depreciation & Amortization
0.280.240.170.160.150.09
Loss (Gain) From Sale of Assets
00-0.0200.01-
Stock-Based Compensation
9.528.763.221.411.432.71
Other Operating Activities
-0.821.74-1.10.550.994.72
Change in Accounts Receivable
-0.4-0.43-0.1-0.10.230.15
Change in Accounts Payable
4.792.36-0.710.581.32-0.5
Change in Other Net Operating Assets
-1.6-2.64-5.954.88-0.040.05
Operating Cash Flow
-32.7-28.55-29.99-20.75-14.4-11.72
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.75-0.59-0.1-0.07-0.24-0.34
Sale of Property, Plant & Equipment
--0.03-0-
Investment in Securities
-79.72---10.07-7.11
Other Investing Activities
------3.97
Investing Cash Flow
-80.47-0.59-0.08-0.079.83-11.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----0.08
Long-Term Debt Issued
-----10.08
Total Debt Issued
-----10.16
Long-Term Debt Repaid
---9.14-0.08-0.14-0.46
Net Debt Issued (Repaid)
---9.14-0.08-0.149.69
Issuance of Common Stock
144.2176.0654.9221.1610.9429.9
Financing Cash Flow
144.2176.0645.7821.0810.839.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
00.54-1.960.82-0.51-0.06
Net Cash Flow
31.0547.4613.761.085.7316.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-33.44-29.14-30.1-20.82-14.63-12.06
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.74-0.73-0.89-0.86-0.76-0.97
Levered Free Cash Flow
-17.57-16.3-20.95-10.78-8.72-12.98
Unlevered Free Cash Flow
-17.57-16.3-20.35-10.05-8.11-12.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.390.60.330.46
Change in Working Capital
2.8-0.71-6.765.351.51-0.3
SEC Filings: 10-K · 10-Q